Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world?
Linda L. Wong, Ruel J. Reyes, Sandi A. Kwee, Brenda Y. Hernandez, Sumodh C. Kalathil, Naoky C. Tsai
Clin Mol Hepatol. 2017;23(3):239-248. Published online 2017 Jul 14 DOI: https://doi.org/10.3350/cmh.2017.0008
Citations to this article as recorded by
Risk factors for biopsy-proven advanced non-alcoholic fatty liver disease in the Veterans Health Administration
Y. A. Patel, E. J. Gifford, L. M. Glass, R. McNeil, M. J. Turner, B. Han, D. Provenzale, S. S. Choi, C. A. Moylan, C. M. Hunt
Alimentary Pharmacology & Therapeutics.2018; 47(2): 268. CrossRef
Surveillance of hepatocellular carcinoma: is only ultrasound enough?
Woo Kyoung Jeong
Clinical and Molecular Hepatology.2017; 23(3): 222. CrossRef